Skip to main content

Table 3 Level of compliance of individual API content and failing rates of anti-malarial samples

From: Post-marketing surveillance of anti-malarial medicines used in Malawi

Anti-malarial sample

Number of samples

Level of compliance of API content

Remarks

Number and rate of failing samples

API

compliant

noncompliant

ATS/SP

4

ATS

4

0

All the 4 samples were noncompliant

4 (100%)

 

S

0

4

 

P

2

2

ATS/SmP

5

ATS

2

3

Compliant APIs did not occur in the same samples therefore all the samples were noncompliant

5 (100%)

  

Sm

1

4

 

P

2

3

ATM/LUM

41

ATM

14

27

Only 2 samples had both APIs being compliant in the same sample.

39 (95.1%)

 

LUM

11

30

DHA/Pp

14

DHA

4

10

Pp API could not be assayed. Based on DHA alone, 4 out of 14 samples were compliant

10 (71.4%)

 

Pp

-

-

DHA/SP

12

DHA

0

12

All the samples were noncompliant even though P was 100% compliant

12 (100%)

 

S

1

11

 

P

12

0

SP

23

S

3

20

Only 2 samples had both APIs being compliant in the same sample

21 (91.3%)

 

P

12

11

QN

13

QN

5

8

5 out 13 samples were compliant

8 (61.5%)

Total

112

 

73

145

 

99 (88.4%)